about
Progesterone receptor membrane component 1 inhibits the activity of drug-metabolizing cytochromes P450 and binds to cytochrome P450 reductaseMembrane position of ibuprofen agrees with suggested access path entrance to cytochrome P450 2C9 active siteA novel type of allosteric regulation: functional cooperativity in monomeric proteinsStructure and dynamics of the membrane-bound cytochrome P450 2C9Identifying cytochrome p450 functional networks and their allosteric regulatory elementsCytochrome P450 system proteins reside in different regions of the endoplasmic reticulum.Interactions among cytochromes P450 in microsomal membranes: oligomerization of cytochromes P450 3A4, 3A5, and 2E1 and its functional consequencesDrug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5.CYP2R1 Mutations Impair Generation of 25-hydroxyvitamin D and Cause an Atypical Form of Vitamin D Deficiency.Identification of cytochrome P450 2C2 protein complexes in mouse liver.Effect of homomeric P450-P450 complexes on P450 function.Immobilized Cytochrome P450 for Monitoring of P450-P450 Interactions and MetabolismInteractions between cytochromes P450 2B4 (CYP2B4) and 1A2 (CYP1A2) lead to alterations in toluene disposition and P450 uncouplingCorrelating structure and function of drug-metabolizing enzymes: progress and ongoing challenges.Physical Studies of P450-P450 Interactions: Predicting Quaternary Structures of P450 Complexes in Membranes from Their X-ray Crystal Structures.Microsomal monooxygenase as a multienzyme system: the role of P450-P450 interactions.Formation of P450 · P450 complexes and their effect on P450 functionRole of Cytochrome P450 2C8 in Drug Metabolism and Interactions.Characterization of interactions among CYP1A2, CYP2B4, and NADPH-cytochrome P450 reductase: Identification of specific protein complexes.Protein-protein and protein-membrane associations in the lignin pathway.Effects of polymorphic variation on the thermostability of heterogenous populations of CYP3A4 and CYP2C9 enzymes in solution
P2860
Q24307533-AA988F3F-29F2-4806-ABEF-DB8A7AAE85FEQ24609983-7AD30C8C-5381-4FBA-8A0E-8EEA3742BC5FQ27011182-CA53FE91-386D-46E0-A78E-71B0B89C4775Q28476533-8A7098DD-5F2C-4FE0-B3EF-0E6E9265675DQ28535773-6D3DD3D1-517E-47B8-A760-49A7AAD68C7DQ35038939-5C0E9570-E5CE-4EC9-BEC5-8863B9AF7222Q35055663-A5CEF7E9-AB77-4EA0-ABC7-4E9BC858D8FBQ35175018-6876F31F-0F9A-4AA8-9044-6FCA62854193Q35813253-1851300D-F7B1-45BE-A4C7-383020AE30BCQ35869046-E342CD40-8CCA-4276-ACEE-D6033E0A44EFQ36456390-5EB9F61E-B9E9-44FE-950B-821C2B75F588Q36852513-CDB3D125-439F-4399-BF0D-A90A7D3C53A9Q37112456-0419FD5D-9575-4C6D-8319-FFAD31553DE0Q37422674-8B66B186-9E8F-4708-A595-2BC8C8265627Q37611698-F70D8C1E-E41B-4C24-98DD-5410232821B1Q37852000-7DC09ABB-A626-4135-960A-18899DD297B4Q37966569-CC8485B9-ED96-4600-9DED-1CAB4D5B4C5FQ38684505-3897951C-1C01-4579-954E-C8C497894084Q47301320-C2938556-8F15-400E-856C-9C0CCB645E11Q50487635-C516EF18-A534-46B6-BB57-679133A1343EQ58796074-C5F56289-4679-4AE5-A595-311CFC8B584E
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
CYP2C8 exists as a dimer in natural membranes.
@ast
CYP2C8 exists as a dimer in natural membranes.
@en
CYP2C8 exists as a dimer in natural membranes.
@nl
type
label
CYP2C8 exists as a dimer in natural membranes.
@ast
CYP2C8 exists as a dimer in natural membranes.
@en
CYP2C8 exists as a dimer in natural membranes.
@nl
prefLabel
CYP2C8 exists as a dimer in natural membranes.
@ast
CYP2C8 exists as a dimer in natural membranes.
@en
CYP2C8 exists as a dimer in natural membranes.
@nl
P2093
P2860
P356
P1476
CYP2C8 exists as a dimer in natural membranes.
@en
P2093
Byron Kemper
Eric F Johnson
P2860
P304
P356
10.1124/DMD.110.034942
P577
2010-08-10T00:00:00Z